减少Lung-RADS评估中间大小结节假阳性筛查结果的策略:国家肺癌筛查试验数据的二次分析
基于NLST数据的回顾性二次分析,由两名胸部放射科医师独立复核223例患者基线CT上的实性中间大小结节(6.0-9.5 mm),比较不同Lung-RADS v1.1分类方案的敏感度与特异度。将任意胸膜下(而非仅叶间裂旁)三角形、多边形或卵圆形结节归为2类,或采用体积而非直径切点,均可提高特异度而不降低敏感度;两策略联合时敏感度85-93%、特异度58-59%。
要点
- 将任意胸膜下(非仅叶间裂旁)三角形、多边形或卵圆形小结节归为2类,特异度由26-31%升至47-51%。
- 采用体积切点替代直径切点,特异度由26-31%升至37%(两名阅片者),敏感度89-93%无显著下降。
- 两策略联合后特异度达58-59%,敏感度85-93%,可减少良性结节的6个月随访复查。
核心结论
- 将任意胸膜下(不仅叶间裂旁)的三角形、多边形或卵圆形中间大小结节归为2类,并采用体积而非直径测量,可在不降低敏感度的情况下提高Lung-RADS特异度。
研究设计与样本
- 回顾性研究,为美国国家肺癌筛查试验(NLST)数据的二次分析;从基线CT上1387个6.0-9.5 mm实性结节中选取38个后来发生癌症患者的结节及200个随机抽取的未发生癌症患者的结节,排除后共223例患者(中位年龄62岁,男143例、女80例;良性结节196个、恶性结节27个);由两名胸部放射科医师独立复核,使用半自动软件记录结节直径与体积,并判定是否为叶间裂旁、其他胸膜下位置及三角形、多边形或卵圆形。
诊断标准与关键数值
- 标准Lung-RADS v1.1:敏感度89-93%、特异度26-31%;将小于10 mm、位于其他胸膜下(而非仅叶间裂旁)的三角形、多边形或卵圆形结节归为2类的修改方案:敏感度85-93%、特异度47-51%;采用体积切点的Lung-RADS v1.1:敏感度89-93%、特异度37%(两名阅片者);两种修改方案敏感度与标准Lung-RADS v1.1均无显著差异(均p > .05),特异度均显著优于标准Lung-RADS v1.1(均p < .05);两策略联合:敏感度85-93%、特异度58-59%。
临床应用与阅片要点
- 作者结论认为,将任意胸膜下(不仅叶间裂旁)的三角形、多边形或卵圆形中间大小结节归为2类并采用体积而非直径测量,可提高Lung-RADS特异度而不降低敏感度,有助于减少良性病变的6个月随访检查。
局限性
- 本文为对NLST数据的回顾性二次分析。
- 仅选取了后来发生癌症患者的38个结节及200个未发生癌症患者的随机样本结节,样本量为223例患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. Lung-RADS version 1.1 (v1.1) classifies all solid nodules less than 6 mm as category 2. Lung-RADS v1.1 also classifies solid intermediate-size (6 to < 10 mm) nodules as category 2 if they are perifissural and have a triangular, polygonal, or ovoid shape (indicative of intrapulmonary lymph nodes). Additional category 2 criteria could reduce false-positive results of screening examinations. OBJECTIVE. The purpose of this study was to evaluate the impact of proposed strategies for reducing false-positive results for intermediate-size nodules on lung cancer screening CT evaluated using Lung-RADS v1.1. METHODS. This retrospective study entailed secondary analysis of National Lung Screening Trial (NLST) data. Of 1387 solid nodules measuring 6.0-9.5 mm on baseline screening CT examinations in the NLST, all 38 nodules in patients who developed cancer and a random sample of 200 nodules in patients who did not develop cancer were selected for further evaluation. Cancers were required to correspond with the baseline nodule on manual review. After exclusions, the sample included 223 patients (median age, 62 years; 143 men, 80 women; 196 benign nodules, 27 malignant nodules). Two thoracic radiologists independently reviewed baseline examinations to record nodule diameter and volume using semiautomated software and to determine whether nodules had perifissural location; other subpleural location; and triangular, polygonal, or ovoid shape. Different schemes for category 2 assignment were compared. RESULTS. Across readers, standard Lung-RADS v1.1 had sensitivity of 89-93% and specificity of 26-31%. A modification assigning nodules less than 10 mm with triangular, polygonal, or ovoid shape in other subpleural locations (vs only perifissural location) as category 2 had sensitivity of 85-93% and specificity of 47-51%. Lung-RADS v1.1 using volume cutoffs had sensitivity of 89-93% and specificity of 37% (both readers). The sensitivity of both modified Lung-RADS v1.1 and Lung-RADS v1.1 with volume cutoffs was not significantly different from standard Lung-RADS v1.1 (all p > .05). However, both schemes' specificity was significantly better than standard Lung-RADS v1.1 (all p < .05). Combining the two strategies yielded sensitivity of 85-93% and specificity of 58-59%. CONCLUSION. Classifying intermediate-size nodules with triangular, polygonal, or ovoid shape in any subpleural (not just perifissural) location as category 2 and using volume- rather than diameter-based measurements improves Lung-RADS specificity without decreased sensitivity. CLINICAL IMPACT. The findings can help reduce false-positive results, decreasing 6-month follow-up examinations for benign findings.
引用
- Hammer, Hunsaker. Strategies for Reducing False-Positive Screening Results for Intermediate-Size Nodules Evaluated Using Lung-RADS: A Secondary Analysis of National Lung Screening Trial Data. AJR Am J Roentgenol. 2022. PMID: 35319912. doi:10.2214/AJR.22.27595
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。